Logo

Molecular Diagnostics

News on lab-developed tests and emerging diagnostic technologies.

Layoffs at Life Science, Dx Firms Continue as Thermo Fisher Scientific, Natera Shrink Payrolls

In 2023, Thermo Fisher has laid off nearly 400 California employees at sites associated with Mesa Biotech, acquired in 2021 for $450 million in cash.

Previse Launches Esophageal Cancer Risk Test, Raises $3M to Support Commercial Expansion

The company hopes to build prospective clinical utility evidence for the Esopredict test, its first clinical assay, to support future reimbursement.

Guardant Health, Ohio State University Partner on Blood-Based Colon Cancer Screening Study

OSU investigators will offer the Guardant Shield assay to patients via mobile phlebotomists, studying adoption rates among approximately 300 individuals.

Invitae, Epic Sign Deal to Integrate Genetic Test Results Into EMR System

Invitae said results from its genetic tests would be made available directly to healthcare providers using Epic's electronic medical record systems.

LumiraDx Q4 Revenues Fall 65 Percent

The company was impacted by a $96.3 million accounting impairment due to excess manufacturing and inventory related to its COVID-19 test scale-up.

Mar 20, 2023

Cue Health Gets FDA EUA for Monkeypox Molecular Test

Mar 20, 2023

DiaSorin Gets FDA 510(k) for Molecular COVID-19/Flu Assay

Mar 17, 2023

ACMG: Rare Disease Patients in Poor Countries See Benefit from Clinical Whole-Genome Sequencing

Mar 16, 2023

Researchers Aim to Boost Liquid Biopsy cfDNA Yields Using Novel Priming Agents
Premium

Mar 16, 2023

Dutch Researchers Craft Glow-in-the-Dark POC Infectious Disease Test
Premium

Mar 16, 2023

GenoMe Diagnostics Preparing Digital PCR-Based Ovarian Cancer Test for US, EU, UK Submissions 
Premium

Mar 16, 2023

Becton Dickinson Gets FDA 510(k) Clearance for High-Throughput Vaginitis Test

Mar 16, 2023

ACMG Statement Says Preimplantation Polygenic Risk Testing 'Not Appropriate for Clinical Use' Yet

Mar 16, 2023

Droplet Biosciences Targets Lymph Fluid in New Residual Cancer Detection Strategy
Premium

Mar 15, 2023

Cue Health Q4 Revenues Drop 24 Percent

Mar 15, 2023

SD Biosensor Eyes Global Expansion as Evaluations Find Rapid MDx System on Par With Competition
Premium

Mar 15, 2023

At ACMG, GUARDIAN Newborn Sequencing Study Reports High Uptake Rate

Mar 15, 2023

GeneDx Q4 Revenues Grow 6 Percent but Miss Consensus Estimate

Mar 15, 2023

Mainz Biomed Partners With Labor Staber to Market ColoAlert Test

Mar 14, 2023

Visby Medical Point-of-Care STI Test Gets FDA 510(k) Clearance, CLIA Waiver

Mar 14, 2023

Oxford Gene Technology Obtains CE-IVDR Certificates for FISH Products

Mar 14, 2023

Grifols Betting on Free OTC Tests to Expand COPD Diagnoses, Treatment
Premium

Mar 14, 2023

Neogap Therapeutics, Simsen Diagnostics Collaborate on Cancer Dx

Mar 14, 2023

Quest Diagnostics Gets FDA Emergency Use Authorization for COVID-19 Sample Collection Kit

Mar 13, 2023

DnaNudge, Mylab Discovery Solutions Forge Dx Partnership for Diabetic Foot Infections

Breaking News
The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.